Coordination Areas
Community

Prioritizing Visibility Through Community Partnerships

The development and engagement of strategic partnerships is a vital component of representing diverse populations in clinical trials and research.

HANC supports Community Partners, The Legacy Project and the COVID-19 CAB Coalition to achieve representation and build relationships with historically underrepresented communities in clinical research. 

Community Partners

Community Partners (CP) is a cross-network body charged by the Network Leadership and the Division of AIDS (DAIDS) with promoting effective representation of the many communities within which the National Institutes of Health (NIH) HIV/AIDS Clinical Trials Networks conduct research.

The Community Partners group is made up of community representatives from the NIH-funded HIV/AIDS Clinical Trials Networks community groups and network staff, including representatives from the AIDS Clinical Trials Group (ACTG), the HIV Prevention Trials Network (HPTN), the HIV Vaccine Trials Network (HVTN), the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT), and the Microbicide Trials Network (MTN). HANC staff and representatives from DAIDS serve as non-voting members.

How does Community Partners work?

Community Partners represents community research needs and priorities to the NIH Clinical Trials Network Leadership (NLG) and Strategic Working Group (SWG) and other advisory groups or committees as needed/requested. CP provides input to DAIDS research plans as they relate to scientific agendas, ethical conduct of clinical trials, community education, community training and communication/information dissemination in a manner that ensures respect for community priorities and continued community participation.

What is Community Partners Doing?

Community Partners focuses on improving intra- and inter-network community input at all levels, identifying and developing programs to meet the training and support requirements of local Community Advisory Boards, increasing the representation and participation of community members from resource-limited settings and vulnerable populations, and identifying and addressing challenges to participation in clinical trials. Community Partners conducts activities regularly through conference calls and online tools such as email and a web portal system that allows for document collaboration and discussion boards.

Community Partners Working Groups

Expand All
Community Partners (CP)

Facilitate and enhance community representation and input at all levels in HIV/AIDS and related clinical research within the networks. Increase knowledge and awareness of CP, CP tools, and network activities.  Support efficiency and effectiveness of local and network community advisory boards and engagement of stakeholders. Address challenges to community engagement in clinical research.

Community Partners Executive Committee

Make decisions on behalf of Community Partners and its general membership in accordance with CP Organizational Guidelines.

Community Partners Ethics Working Group

Identify opportunities for improvement and work in collaboration with DAIDS to provide guidance to researchers, communities and stakeholders regarding the ethical considerations and challenges in research with individuals facing stigma, discrimination, legal sanctions and/or interpersonal violence, and social harms.

Community Research Priorities Working Group

Improve and promote transgender inclusion as outlined in the CP Memorandum, including working with DAIDS, the Networks and other groups to encourage adoption and implementation of the recommendations. Review and make recommendations regarding Standard of Care issues for community members.  In partnership with CP Ethics WG, review and address understanding of IC among CABs. Continue to review and make recommendations on co-endorsed protocols to ensure community input.

Community Training Working Group (CT)

Develop a strategy to disseminate and promote new or standardized cross-network Community Partners training materials to Networks, Sites, and other community groups.  Assess the value of materials and determine additional priority topics. Work to make CP training modules on the DAIDS LMS available in an open access forum.

Share existing CAB training materials, identify and develop new or standardized cross-network CAB training materials when there are unmet training needs or a strong rationale for standardized modules.

The Legacy Project

The Legacy Project works nationally to increase awareness of and build support for HIV prevention and treatment clinical and behavioral research by addressing factors that influence participation of historically underrepresented communities. The Legacy Project achieves its core mission through ongoing and strategic engagement, collaboration, education, and scientific investigation.

A group of women collaborating in a meeting

Our Vision

The Legacy Project envisions accurately informed communities actively engaged in clinical research with culturally sensitive research environments and processes.

Our Mission

The Legacy Project works to increase representation and engagement of minorities and marginalized communities in HIV clinical research in the U.S.

Working Groups and Projects

With a team of diverse, skilled and devoted staff, the Legacy Project works to cultivate and enhance partnerships and relationships among the National Institutes of Health (NIH) HIV/AIDS Clinical Trials Networks and research sites, research and academic institutions, governmental agencies, community-based organizations and affiliates, while ensuring a commitment to capacity building for communities and populations most impacted by the HIV epidemic in the United States.

Expand All
Legacy Project Working Group

The Legacy Project Work Group (LPWG) is comprised of members from HANC, Community Partners, the Women’s HIV Research Collaborative, network operations centers, clinical research site representatives, DAIDS, the DAIDS Cross-Network Transgender Working Group, Office of AIDS Research and other NIH Institutes and Centers. The LPWG ensures that the HANC Legacy Project assists the DAIDS-funded HIV clinical trials networks to achieve increased representation and engagement of historically underrepresented communities in HIV clinical research across the U.S. These communities include, but are not limited to:

  • African-American/Black Communities
  • American Indian/Alaska Native Communities
  • Hispanic/Latinx Communities 
  • Men Who Have Sex With Men/Same-Gender-Loving
  • Transgender Communities
  • Women

Setting program objectives and monitoring progress toward those objectives are the fundamental tasks of this group. The LPWG works with HANC staff to establish an annual strategic plan with objectives that are specific, measurable, achievable, relevant, and time-bound.

View Legacy Project Work Plan

Be the Generation

Be the Generation (BTG) is a project that builds community capacity to end the HIV epidemic through scientific literacy and engagement with biomedical HIV prevention research, focusing on microbicides, PrEP, TasP, and vaccines. Initiated in 2006 by the National Institute of Allergy and Infectious Diseases to create support for HIV vaccine research, BTG is now managed by the Legacy Project to promote the work of the NIH-funded HIV prevention research agenda more broadly. The Legacy Project maintains the commitment to provide the community with accurate information and resources for HIV prevention research in three ways:

Please visit Be the Generation for access to these resources and more information.

Cross-Network Transgender Working Group (CNTWG)

In 2015, the Division of AIDS at the National Institute of Allergy and Infectious Diseases established a Cross-Network Transgender Working Group. The group’s goals are to foster coordination, collaboration, and an exchange of information related to transgender issues across the NIH-funded HIV/AIDS Clinical Trials Networks. While the CNTWG is managed by the Division of AIDS, the Legacy Project plays an instrumental role in the working group and the development of its resources, namely:

Conference Engagement Working Group

The Legacy Project Conference Engagement Working Group helps coordinate and plan presentations at conferences including the US Conference on HIV/AIDS, the NMAC Biomedical HIV Prevention Summit, the International AIDS Conference, and many more.

New Investigators Working Group

The New Investigators Working Group supports cross-network collaboration by promoting the various Network’s Scholars Programs while strategically promoting the involvement of underrepresented investigators.

Women's HIV Research Collaborative (WHRC)

The WHRC is a cross-network working group of the Legacy Project comprised of women who are leaders in women’s health and HIV from around the United States. With community and staff representatives from all five NIH-funded HIV/AIDS clinical trials networks, this group provides culturally appropriate guidance and leadership in development, implementation, and dissemination of information about HIV research focused on and responsive to the needs of cisgender and transgender women and girls in the United States.

The WHRC works to raise the visibility of issues related to HIV in women in the US and promote awareness of scientific research for women in disproportionately impacted communities. The WHRC focuses on advocating for HIV research with women living in the United States but operates with a comprehensive awareness of the potential for American women to benefit from HIV research that is being conducted internationally. To that end, WHRC’s focus is domestic, but its interests are both global and optimistic.

View WHRC Work Plan
Biomedical HIV Prevention for Women Training
Women & HIV Cure-Related Research Training
National Women & Girls HIV/AIDS Awareness Day Infographic

COVID-19 CAB Coalition

The HANC-facilitated COVID-19 CAB Coalition formed in September 2020 to share information, facilitate resource sharing, and advocate on the behalf of the overall COVID-19 research efforts. Current group members represent the COVID-19 Prevention Network (CoVPN) Community Engagement Working Group, ACTG's ACTIV-2 CAB, AVAC's COVID Advocates Advisory Board, the CFAR National CAB Coalition, the COVID-19 ​​​​​​​​CAB at Stony Brook, DAIDS, and Community Partners.​

A woman walks down a busy city street in a protective face mask and gloves.

Find resources on how to become a participant in clinical research, community engagement materials, important social media accounts to follow, ​​​webinars on COVID-19, and other useful information on our COVID-19 resources page.